RecruitingNot ApplicableNCT07436806

SPS Block vs. Surgical Intercostal Block for Chronic Pain After Thoracoscopic Surgery

Evaluation of Serratus Posterior Superior (SPS) Block Versus Surgical Intercostal Blockade in Preventing Chronic Post-Thoracotomy Pain After Video-Assisted Thoracoscopic Surgery (VATS): A Randomized, Prospective, Comparative Study.


Sponsor

Medipol University

Enrollment

40 participants

Start Date

Mar 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to evaluate the efficacy of ultrasound-guided Serratus Posterior Superior (SPS) block compared to surgeon-administered intercostal blockade in preventing chronic pain at 3, 6, and 12 months following Video-Assisted Thoracoscopic Surgery (VATS).


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria2

  • ASA physical status I-III.
  • Scheduled for elective unilateral Video-Assisted Thoracoscopic Surgery (VATS).

Exclusion Criteria5

  • History of allergy to local anesthetics.
  • Pre-existing chronic pain syndrome or neuropathic pain.
  • Psychiatric disorders affecting pain assessment.
  • Coagulation disorders.
  • Previous thoracic surgery on the same side.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSPS block

30 mL of 0.25% Bupivacaine will be injected into the plane between the Serratus Posterior Superior muscle and the intercostal muscles at the scapular level.

DRUGSurgical Intercostal Blockade.

At the end of the operation, the surgeon will perform an injection of a total of 30 mL of 0.25% Bupivacaine into three intercostal nerves above and below the incision site under direct thoracoscopic visualization.


Locations(1)

Istanbul Medipol University Hospital

Istanbul, Bagcilar, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07436806


Related Trials